Stocks and Investing Stocks and Investing
Wed, February 23, 2022
Tue, February 22, 2022

Andrew Berens Maintained (AGIO) at Hold with Decreased Target to $30 on, Feb 22nd, 2022


Published on 2024-10-27 19:46:33 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Leerink, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Hold with Decreased Target from $32 to $30 on, Feb 22nd, 2022.

Andrew has made no other calls on AGIO in the last 4 months.



There are 3 other peers that have a rating on AGIO. Out of the 3 peers that are also analyzing AGIO, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Andrew


  • Michael King of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $98 on, Friday, February 18th, 2022
  • John Newman of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $44 on, Wednesday, February 16th, 2022
  • Greg Harrison of "B of A Securities" Initiated at Strong Buy and Held Target at $54 on, Friday, December 3rd, 2021

Contributing Sources